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Abstract 
KISS1 and  its  receptor,  KISS1R,  have  both
been found to be expressed in central nervous
system, but few data are present in the litera-
ture about their distribution in peripheral nerv-
ous structures. Thus, the aim of the present
study was to investigate, through immunohisto-
chemistry,  the  expression  and  distribution  of
KISS1 and KISS1R in the rat and human carotid
bodies and superior cervical ganglia, also with
particular  reference  to  the  different  cellular
populations. Materials consisted of carotid bod-
ies and superior cervical ganglia were obtained
at autopsy from 10 adult subjects and sampled
from  10  adult  Sprague-Dawley  rats.
Immunohistochemistry revealed diffuse expres-
sion of KISS1 and KISS1R in type I cells of both
human and rat carotid bodies, whereas type II
cells  were  negative.  In  both  human  and  rat
superior  cervical  ganglia  positive  anti-KISS1
and -KISS1R immunostainings were also selec-
tively  found  in  ganglion  cells,  satellite  cells
being negative. Endothelial cells also showed
moderate immunostaining for both KISS1 and
KISS1R. The expression of both kisspeptins and
kisspeptin receptors in glomic type I cells and
sympathetic ganglion cells supports a modulato-
ry role of KISS1 on peripheral chemoreception
and  sympathetic  function.  Moreover,  local
changes in blood flow have been considered to
be involved in carotid body chemoreceptor dis-
charge and kisspeptins and kisspeptin receptors
have also been found in the endothelial cells. As
a consequence, a possible role of kisspeptins in
the regulation of carotid body blood flow and,
indirectly, in chemoreceptor discharge may also
be hypothesized.
Introduction
The  KISS1  gene  was  originally  identified
through  a  differential  expression  approach
showing  up  regulation  of  its  expression  in
tumor cells which had lost their potential to
metastize.1-3 It encodes for a 145 amino acid
precursor,  which  can  be  cleaved  into  a  54
amino acid protein, originally called metastin,
or shorter 14, 13 and 10 amino acid peptides,
which share a common C-terminal amidation
site. With the term of kisspeptins are collec-
tively named all the peptides cleaved from the
precursor hormone. The larger protein shows
some variability among species whereas the C-
terminal 10 amino acid sequence is well con-
served.1,4-6
The kisspeptin receptor, now called KISS1R
in humans and Kiss1r in rodents,7 was initial-
ly discovered in rats in 1999 as an orphan G
protein-coupled  membrane  receptor  named
GPR54,8 in 2001 kisspeptins being identified
as its natural ligands.4-6,9 Its gene shares mod-
est  homology  with  the  gene  coding  for  the
galanin receptor 2, although kisspeptins do not
bind the above galanin receptor.8
Kisspeptins play a crucial role in the control
of  puberty  onset  and  reproductive  function.
Apart from central nervous system, KISS1 and
KISS1R  have  both  been  found  to  be  widely
expressed in many other tissues such as the
pituitary,  gonads,  placenta,  pancreas,  liver,
intestines  and  vessels.1,5,6,10,11 As  it  concerns
the peripheral nervous system, both KISS1 and
KISS1R  have  recently  been  found  to  be
expressed in rat dorsal root ganglion.12 To the
best  of  our  knowledge,  there  are  no  data
regarding  expression  of  kisspeptin  and
kisspeptin  receptor  in  the  carotid  body  and
sympathetic ganglia. 
The carotid body is the main peripheral arte-
rial chemoreceptor, inducing increases in ven-
tilatory volume and frequency in response to
hypoxia, hypercapnia, or reduction of blood pH.
It is organized in lobules of cells belonging to
two  different  populations:  type  I  cells,  with
roundish shape and higher dimensions, and
type II cells, with fusiform shape and located at
the edges of the clusters. Type I cells represent
the real chemoreceptor elements. In response
to the various stimuli they release many differ-
ent neurotransmitters and neuromodulators,13-
17 which mainly act on the glosso-pharyngeal
afferent fibers arising from the petrosal gan-
glion. However, substances released from type
I cells may also act on other components of the
carotid body, such as type I cells themselves
(through  autocrine  and  paracrin  mecha-
nisms), type II cells, vessels, and connective
cells. Type II cells show astrocytic markers and
play a supportive role, but it has recently been
observed that if exposed to prolonged hypoxia
they may also behave as stem cells precursor
for type I cells.18 The carotid body also shows
parasympathetic and sympathetic innervation,
the  latter  mainly  from  the  superior  cervical
ganglion.
The aim of the present study was therefore
to investigate, through immunohistochemistry
and real-time RT-PCR, the expression and dis-
tribution of KISS1 and KISS1R in the rat and
human carotid body and superior cervical gan-
glia, also with particular reference to the dif-
ferent cellular populations.
Materials and Methods
Tissue sampling and preparation
Materials  consisted  of  carotid  bodies  and
superior cervical ganglia obtained at autopsy
from  10  adult  subjects  [6  males,  4  females;
mean  age  46  years,  standard  deviation
(SD)±3.6], clinically negative for chronic pul-
monary or cardiovascular diseases, and sam-
pled  from  10  adult  Sprague-Dawley  rats.
Autopsies were performed between 24 and 30 h
after death. 
Sampling  from  rats  was  performed  soon
after sacrifice. Right carotid bifurcations and
superior  cervical  ganglia  from  humans  and
rats were fixed in Bouin solution and embed-
ded in paraffin wax. 
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Immunohistochemical analysis
Immunohistochemical  examinations  were
carried out on 3 mm thick sections. For anti-
KISS1R  immunohistochemistry,  unmasking
was  performed  with  10  mM  sodium  citrate
buffer, pH 6.0, at 90°C for 30 min. For anti-
KISS1 immunohistochemistry, antigen unma  -
sking was not necessary. Sections were incu-
bated in 0.03% hydrogen peroxide for 10 min at
room temperature, to remove endogenous per-
oxidase activity, and then in blocking serum
(0.04% bovine serum albumin, A2153, Sigma-
Aldrich,  Milan,  Italy  and  0.5%  normal  goat
serum X0907, Dako Corporation, Carpinteria,
CA, USA, in PBS) for 30 min at room tempera-
ture. Primary anti-KISS1 antibody (rabbit poly-
clonal  antibody  anti-metastin  [1-25)/KISS-1
(68-92),  Catalog  No.  H-048-62,  Phoenix
Pharmaceuticals, Inc., Burlingame, CA, USA]
was diluted 1:1500 in blocking serum. Primary
anti-KISS1R antibody (rabbit polyclonal anti-
body anti-AXOR12 (375-398), Catalog No. H-
048-61,  Phoenix  Pharma  ceuticals,  Inc.,)  was
diluted 1:100 in blocking serum. Both antibod-
ies were incubated overnight at 4°C.  Sections
were then washed three times for 5 min in
PBS. Sections were revealed with anti-rabbit
serum  (DAKO® EnVision  +  TM  Peroxidase,
Rabbit, Dako Corporation) for 30 min at room
temperature. Finally, sections were developed
in  3,3’-diaminobenzidine  (DAB,  Sigma-
Aldrich) and counterstained with hematoxylin.
Negative controls were performed by omission
of  primary  antibody  and  absorption  tests.
Immunoreactions detected in human placenta
and rat brain were used as positive controls. 
The  percentages  of  type  I  and  II  positive
cells were evaluated on fields of 180ﾥ134 mm.
Five  sections  and  3  fields  per  section  were
examined. In rat and human carotid bodies,
about 40 and 25-30 type I cells were counted for
each field, respectively. The mean percentages
of positive cells were calculated for each case
and for the entire series.
Statistics
Percentages obtained were compared with
Mann-Whitney test. A P value of 0.05 was con-
sidered significant. 
Results
Immunohistochemistry  revealed  diffuse
expression of kisspeptins and receptor in type
I cells of both human and rat carotid bodies.
Immunostained cells were distributed both in
the centre and in the periphery of the lobules.
Conversely,  no  kisspeptins  or  receptor
immunostainings were observed in type II cells
(Figure 1). Endothelial cells of some vessels
also  showed  moderate  immunostaining  for
both KISS1 and KISS1R.
In  both  human  and  rat  superior  cervical
ganglia  positive  anti-KISS1  and  –KISS1R
immunostainings  were  selectively  found  in
ganglion cells. Satellite cells were negative or
only showed weak reaction (Figure 2). Glomic
and  ganglion  cell  immunostainings  were
eliminated when preabsorbed antiserum was
used or primary antibodies were omitted.
Discussion
To the best of our knowledge, this is the first
study demonstrating kisspeptin and kisspeptin
receptor  expression  in  glomic  type  I  cells
through immunohistochemistry. In the carotid
body, glomic type I cells release many neuro-
transmitters and peptide neuromodulators that
play a role in the regulation of chemoreceptor
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Figure 1. Anti-KISS1 immunohistochemistry in human (A,B,E,F) and rat (C,D,G,H)
carotid bodies (A-D) and superior cervical ganglia (E-H), showing selective positivity of
glomic type I cells (arrows) and ganglionic cells, immunostaining being largely eliminat-
ed in negative controls (B,D,F,H). Note also negativity of type II cells (asterisks) in the
carotid  body  and  of  satellite  cells  in  the  superior  cervical  ganglia.  Scale  bars:  A-D, 
37.5 mm; E-H, 75 mm.[page 80] [European Journal of Histochemistry 2011; 55:e14]
discharge.13-15,19,20 Our findings about expres-
sion of both KISS1 and KISS1R in type I cells,
which represent the real chemoreceptive ele-
ment of the carotid body, support a modulato-
ry  role  of  KISS1  on  peripheral  chemorecep-
tion. Kisspeptins have been found to directly
stimulate excitability of neurons, such as the
granule  cells  of  the  dentate  gyrus,21 and  to
modulate the release of other peptides, such
as  in  hypophysis22 and  islets  of
Langherans.23,24 Thus, also in the carotid body
kisspeptins could act on excitability of type I
cells and/or on their release of peptide neuro-
modulators. Further functional studies will be
necessary to clarify the effects of kisspeptins
on  chemosensory  process  in  glomic  cells.
Kisspeptin  receptor  probably  preferentially
bind peptides locally released in the carotid
body  but  circulating  factors  have  also  been
reported to act on carotid body type I cells, and
possible  actions  by  blood-borne  kisspeptins
may not be excluded. 
The possible role of kisspeptins in the car-
diovascular system has also recently been con-
sidered. The carotid body is the structure in
the body with the highest blood flow (about
1400 or 2000 mL/100 g/min in the cat, depend-
ing on the technique for determination of tis-
sue blood flow),25,26 and local changes in blood
flow have been considered to be involved in
carotid  body  chemoreceptor  discharge.20,27,28
KISS1R  and  KISS1  have  been  found  to  be
expressed in the endothelial cells of the aorta,
coronary  artery  and  umbilical  vein  and
kisspeptins have been demonstrated to show
potent vasoconstrictor action.10 In the present
work anti-KISS1 and – KISS1R immunoreac-
tions were also found in endothelial cells of
some vessels, as a consequence a possible role
of kisspeptins in the regulation of carotid body
blood  flow  and,  indirectly,  in  chemoreceptor
discharge may be hypothesized.
Kisspeptins could also show trophic actions
on glomic cells. In the pre- and postnatal peri-
ods  the  carotid  body  undergoes  structural
changes, mediated by trophic factors, includ-
ing carotid body volume increase, proliferation
of type I, type II, endothelial and Schwann cells
lining peripheral nerve fibers and increased
number  of  synapses  between  type  I  and  II
cells.15,29 Moreover, environmental stimuli (for
instance, hypoxic, hyperoxic or inflammatory
noxae) may also cause a series of morphologi-
cal, cellular and biochemical changes.29-34 For
instance, chronic hypoxia has been shown to
increase  O2 sensitivity  in  the  carotid  body
through  changes  in  molecular  chemorecep-
tors, ion channels and neurochemicals.35-37 The
above changes are mediated by a wide series
of trophic factors. It may also be hypothesized
that kisspeptins released by type I cells may
modulate the expression and effects of trophic
factors  in  the  carotid  body.  For  instance,
kisspeptins have been found to increase BDNF
expression in hippocampal slice cultures,38 and
this growth factor has been identified in type I
cells and nerve fibers of rat carotid body.15,39,40 
In the literature, KISS1 and KISS1R have been
found to be expressed in the dorsal root ganglia
and to be upregulated after intraarticular injec-
tion of the complete Freund’s adjuvant, suggest-
ing possible involvement in chronic inflammato-
ry  pain.12 In  the  present  work,  expressions  of
both KISS1 and KISS1R were found in ganglion
cells of the human and rat superior cervical gan-
glia.  Thus,  it  may  be  hypothesized  a  role  of
kisspeptins also in the modulation of the sympa-
thetic  function,  probably  mainly  through
autocrine or paracrine mechanisms.
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Figure 2. Anti-KISS1R immunohistochemistry in human (A,B,E,F) and rat (C,D,G,H)
carotid bodies (A-D) and superior cervical ganglia (E-H), showing selective positivity of
glomic type I cells and ganglionic cells, immunostaining being largely eliminated in neg-
ative controls (B,D,F,H).  Note also negativity of type II cells (asterisks) in the carotid
body and of satellite cells in the superior cervical ganglia. Scale bars: A, D, 23.8 mm; B,
C, E, F, 37.5 mm; G-H, 75 mm.[European Journal of Histochemistry 2011; 55:e14] [page 81]
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